Health TrialsbyHealthPanel

An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence

ConditionHead and Neck Carcinoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Southern California

About this trial

This study evaluates the cell and biomarkers associated with the aggressive behavior of cancer.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosis/disease status: New diagnosis of head and neck cancer

Allowable type and amount of prior therapy: No prior treatment

Age ≥ 18 years.

Ability to understand and the willingness to sign a written informed consent.

Disqualifiers

Patients who have had treatment of head and neck cancer

Trial population

Patients with a new diagnosis of head and neck cancer

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Non-Interventional Study

    Other intervention

    Non-interventional study

Treatment groups

50 Participants
are divided into 1 treatment group
Group A: Observational1 intervention

Trial outcomes

Primary outcomes

1

Overall survival

Time frame
Up to 5 years
2

Disease free survival

Time frame
Up to 5 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Southern California

Lead sponsor

National Cancer Institute (NCI)

Collaborator

American Academy of Otolaryngology-Head and Neck Surgery Foundation

Collaborator

Source ClinicalTrials.gov
Apply now